Scott Ravech will continue as CEO with global oversight of the newly combined company, but Steen Andersen, Bifodan’s CEO has been named president of Deerland Probiotics and Enyzmes International.
Photo © iStockphoto.com
Deerland Probiotics and Enzymes (Kennesaw, GA) has acquired Bifodan A/S (Hundested, Denmark), expanding its global footprint. A life science company specializing in developing, manufacturing, and distributing probiotic product solutions as private label dietary supplements, medical devices, and over the counter drugs, Bifodan is now a wholly owned subsidiary of Deerland.
Scott Ravech will continue as CEO with global oversight of the newly combined company, but Steen Andersen, Bifodan’s CEO has been named president of Deerland Probiotics and Enyzmes International. Andersen will be responsible for the Hundested site and all activities outside the Americas.
“We believe this investment will allow us to bring even greater value to our respective customers and to the enzyme and probiotic industries we serve,” said Ravech, in a press release. “Deerland and Bifodan are leaders in their respective markets. Bringing together this expertise will benefit both companies, our employees, and our customers.”
NutriSciences Innovations announces acquisition of XSTO Solutions
October 22nd 2024According to the company’s press release, the strategic acquisition adds six new branded products to the NutriScience portfolio, strengthening its role as a preferred ingredient supplier to leading brands in the wellness, food, and beverage industries.